Quince Therapeutics <QNCX.O>: Oppenheimer Initiates Coverage With Outperform Rating; Price Target $82
QNCX•Related News
Cadbury parent Mondelez up after beating quarterly estimates
MDLZ•
Qualcomm completes acquisition of AI software firm Modular
QCOM•
P&G forecasts slower annual sales growth as cost headwinds weigh
PG•
OMA announces availability of 2025 sustainability report
OMAB•
HeartSciences files preliminary proxy for Fortitude Mining deal with DCG unit
HSCS•